Percutaneous PFO closure, further data but many unanswered questions

European Heart Journal

Volumn 27, Issue 3, 2006, Pages 258-259

  Thomson, John D R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; EDITORIAL; HEART ATRIUM SEPTUM DEFECT; HUMAN; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HEART SEPTAL DEFECTS, ATRIAL; HUMANS;

EID: 30744472608     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi671     Document Type: Editorial

References (10)

1. Thompson T, Evans W. Paradoxical embolism. Q J Med 1930;23:135-150.
2. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of a patent foramen ovale in patients with stroke. N Eng J Med 1988;318:1148-1152.
3. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-672.
4. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.
5. Tobis J. The case for closing PFOs. Catheter Cardiovasc Interv 2002;55:195-196.
6. Spies C, Strasheim R, Timmermanns I, Schraeder R. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J 2006;27:365-371. First published on October 27, 2005, doi:10.1093/eurheartj/ehi617.
7. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H, Seiler C, Meier B. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90:186-190.
8. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
9. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive cases. J Am Coll Cardiol 2004;43:302-309.
10. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003;16:39-42.